EICHOR
● Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Condition: Metastatic Colorectal Cancer · Sponsor: Amgen
About this study
The aim of this study is to compare progression free survival (PFS) in treatment-naïve participants with KRAS p.G12C mutated metastatic colorectal cancer (mCRC) receiving sotorasib, panitumumab and FOLFIRI vs FOLFIRI with or without bevacizumab-awwb.
This description comes directly from the study's public registry record.
Talk to the study team
Amgen Call Center · 866-572-6436 · medinfo@amgen.com
Always discuss trial participation with your own doctor first.
Locations (291)
| Ironwood Cancer and Research Centers Scottsdale | Chandler, Arizona, United States | Recruiting |
| Providence Saint Jude Medical Center | Fullerton, California, United States | Terminated |
| City of Hope National Medical Center | Long Beach, California, United States | Recruiting |
| Cancer and Blood Research Center, LLC | Los Alamitos, California, United States | Recruiting |
| California Research Institute | Los Angeles, California, United States | Recruiting |
| Norwalk Hospital | Norwalk, Connecticut, United States | Terminated |
| Cancer Specialists of North Florida - Southpoint | Jacksonville, Florida, United States | Recruiting |
| D and H Cancer Research Center | Margate, Florida, United States | Terminated |
| Mid Florida Hematology and Oncology Centers PA | Orange City, Florida, United States | Terminated |
| Boca Raton Clinical Research Medical Center Inc | Plantation, Florida, United States | Terminated |
| Georgia Cancer Specialists | Atlanta, Georgia, United States | Terminated |
| Insight Research Institute | Chicago, Illinois, United States | Recruiting |
+ 279 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.